1. Advanced prostate cancer: developing gonadotropin-releasing hormone analogues Publication: Silver Spring, MD : Center for Drug Evaluation and Research, May 2022 Subject(s): Drug Development -- legislation & jurisprudenceGonadotropin-Releasing HormoneProstatic Neoplasms -- drug therapyUnited StatesUnited States. Department of Health and Human ServicesUnited States. Food and Drug Administration
